
I was recently grousing about the individualized nature of multiple myeloma. In this modern day, we have some cancers that are curable, and many that are so predictable in their course that treatment is standardized.
Multiple myeloma is not either of those types of cancers. What works for you will not work for me and vice versa. Some of you started with MGUS or smoldering myeloma. Some of you may never advance beyond that. Others, and I am in …
Read the full story »

Santa left some small, cheap jigsaw puzzles in our stockings. They are flimsy and garishly colored. Last week, we cleared off a coffee table, cut one box open, and spread out the pieces.
Jigsaw puzzles can be huge time sinks, as much as any electronic entertainment. This particular puzzle is of a carousel horse, its colors tinted towards the Fauvism spectrum. It has 660 pieces, over 600 of which look identical to the casual eye. No wonder an hour can …
Read the full story »

I have been on Pomalyst (pomalidomide), plus Kyprolis (carfilzomib) and dexamethasone (Decadron), since this past July. It has been an interesting journey, to say the least.
Like Revlimid (lenalidomide) before it, Pomalyst showered me with lots of side effects, ranging from a bright red rash the first cycle, to peeling face and scalp, to extreme cold chills in the middle of the night, to hands shaking so violently that I could not take a picture and get a crisp …
Read the full story »

I have been silent for a couple of months, dealing with sea changes to my treatment regimen. These changes have thrown some major stumbling blocks into my life, and I am not yet ready to write about that increasingly touchy topic.
Fortunately, an intriguing and intense conversation with my good friend and sister-in-law Margaret provided me with a conundrum to puzzle over and this month’s column topic to boot.
I don’t have any answers, but readers might.
Margaret and I …
Read the full story »

“You’ll be an N of 1,” said Tim, my oncologist.
I winced inside. My oncologist had no way of knowing it, but he had inadvertently evoked a Beacon column written by Arnie Goodman, who died in 2014.
Arnie Goodman was a favorite of mine because he didn’t mince words about his condition, which grew increasingly dire. In his column, “N of 1,” Arnie explained that he and his oncologist were trying a new drug,
Read the full story »

Call me Tik-Tok.
Tik-Tok was the mechanical man created by L. Frank Baum and introduced in Ozma of Oz. While he appears in other Oz books, it is in his debut that the reader gains an appreciation for Tik-Tok’s mechanical works, including his apparently tireless activities.
There was one catch with Tik-Tok. As a mechanical man, he had to be wound: under his left arm for thinking, under his right arm for speech, and in the center of his back …
Read the full story »

The infusion regimen I follow for Kyprolis (carfilzomib) is two consecutive days a week, three consecutive weeks in a round, rest one week, repeat. Each session lasts two hours, more or less, so in any complete round of treatment I spend 12 or more hours of enforced downtime, sitting in a chair while chemicals drip into my body.
What to do, what to do?
I don’t carry a tablet. I don’t have a smart phone, just a way …
Read the full story »